Free Trial

Enovix (NASDAQ:ENVX) Shares Gap Up - What's Next?

Enovix logo with Oils/Energy background

Shares of Enovix Co. (NASDAQ:ENVX - Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $8.03, but opened at $8.35. Enovix shares last traded at $8.80, with a volume of 1,512,940 shares traded.

Analyst Ratings Changes

A number of equities research analysts have commented on ENVX shares. Janney Montgomery Scott cut Enovix from a "buy" rating to a "neutral" rating and set a $10.00 price target for the company. in a research note on Thursday, October 31st. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $30.00 price objective on shares of Enovix in a research report on Wednesday, October 30th. Benchmark reissued a "buy" rating and set a $25.00 target price on shares of Enovix in a research report on Wednesday, October 30th. Oppenheimer reaffirmed an "outperform" rating and issued a $36.00 price target on shares of Enovix in a report on Monday, August 26th. Finally, JPMorgan Chase & Co. dropped their price objective on shares of Enovix from $18.00 to $15.00 and set an "overweight" rating on the stock in a report on Tuesday, October 22nd. Two research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, Enovix currently has a consensus rating of "Moderate Buy" and an average price target of $20.50.

Get Our Latest Stock Report on ENVX

Enovix Trading Up 21.2 %

The company has a debt-to-equity ratio of 0.99, a current ratio of 3.77 and a quick ratio of 3.61. The stock has a market cap of $1.73 billion, a PE ratio of -6.04 and a beta of 1.94. The company's fifty day moving average is $9.68 and its 200-day moving average is $11.19.

Enovix (NASDAQ:ENVX - Get Free Report) last released its quarterly earnings data on Tuesday, October 29th. The company reported ($0.17) earnings per share for the quarter, beating analysts' consensus estimates of ($0.20) by $0.03. Enovix had a negative return on equity of 102.19% and a negative net margin of 1,180.21%. The business had revenue of $4.30 million during the quarter, compared to analyst estimates of $4.11 million. During the same quarter last year, the business posted ($0.27) EPS. On average, analysts predict that Enovix Co. will post -1.17 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Enovix news, insider Arthi Chakravarthy sold 35,000 shares of the company's stock in a transaction dated Monday, October 14th. The shares were sold at an average price of $13.00, for a total value of $455,000.00. Following the completion of the transaction, the insider now owns 343,305 shares in the company, valued at approximately $4,462,965. This represents a 9.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Betsy S. Atkins sold 75,000 shares of the firm's stock in a transaction dated Tuesday, December 3rd. The shares were sold at an average price of $9.73, for a total value of $729,750.00. Following the sale, the director now owns 99,497 shares in the company, valued at $968,105.81. This trade represents a 42.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 15.70% of the company's stock.

Hedge Funds Weigh In On Enovix

A number of hedge funds have recently bought and sold shares of ENVX. Oppenheimer & Co. Inc. raised its stake in shares of Enovix by 52.2% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 272,047 shares of the company's stock worth $2,541,000 after buying an additional 93,303 shares during the period. Stifel Financial Corp raised its position in Enovix by 6.2% during the third quarter. Stifel Financial Corp now owns 950,202 shares of the company's stock worth $8,875,000 after acquiring an additional 55,094 shares during the period. One Wealth Advisors LLC purchased a new position in Enovix during the third quarter valued at $700,000. Driehaus Capital Management LLC lifted its holdings in Enovix by 63.7% during the second quarter. Driehaus Capital Management LLC now owns 3,886,492 shares of the company's stock valued at $60,085,000 after purchasing an additional 1,512,424 shares in the last quarter. Finally, Scientech Research LLC purchased a new stake in shares of Enovix during the second quarter worth about $834,000. Hedge funds and other institutional investors own 50.92% of the company's stock.

Enovix Company Profile

(Get Free Report)

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.

Featured Articles

Should you invest $1,000 in Enovix right now?

Before you consider Enovix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.

While Enovix currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines